![David Roblin](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David Roblin
Direttore/Membro del Consiglio presso
NXERA PHARMA CO., LTD.
Profilo
Dr. David Roblin, MD, is a Chairman at Centauri Therapeutics Ltd., a Chief Executive Officer at Relation Therapeutics Ltd., a Chief Operating Officer at Juvenescence Ltd., an Independent Outside Director at Nxera Pharma Co., Ltd. and a Chairman-Scientific Translation at The Francis Crick Institute Ltd. He is on the Board of Directors at Nxera Pharma Co., Ltd. and MedCity Ltd. Dr. Roblin was previously employed as a Chief Operating & Medical Officer by Summit Therapeutics Plc, a Chief Operating Officer by The Francis Crick Institute Ltd., a Chief Medical Officer by Creabilis Therapeutics Srl, a Chief Medical Officer by Creabilis SA, a Chief Medical Officer by Pfizer Inc., a Head-Therapy Area by Bayer AG, a Chief Medical Officer by Creabilis Holdings Ltd., and a Chairman-Research Directors Group by European Federation of Pharmaceutical Industries & Assns.
He also served on the board at Destiny Pharma Plc.
He received his undergraduate degree from the University College London.
Posizioni attive di David Roblin
| Società | Posizione | Inizio |
|---|---|---|
| NXERA PHARMA CO., LTD. | Direttore/Membro del Consiglio | 22/06/2018 |
MedCity Ltd.
 MedCity Ltd. MedCity Ltd. is a central organization dedicated to accelerating innovation, investment, and growth within the life sciences sector. The private company is based in Canterbury, UK. It supports a broad range of life sciences companies—including biotech, medtech, diagnostics, digital health, and advanced therapies—by providing expert guidance, tailored business growth services, and access to a network of investors, academia, industry, and the NHS. MedCity runs programs such as Grow, Health Accelerator for Social Enterprise, TechBio Boost, Collaborate to Innovate, and the Investment Hub, which offer accelerators, seed funding, pitch events, mentorship, and strategic partnerships to help SMEs scale, secure investment, and expand internationally. The organization facilitates connections between SMEs and a network of over 400 angel and venture capital investors, and offers a free brokerage service to help companies find R&D and manufacturing lab space across key life science clusters. MedCity provides resources including setup guides for companies relocating or investing, market intelligence reports, sector analyses, and updates on funding and regulatory developments. Through events and newsletters, MedCity keeps stakeholders informed and engaged, emphasizing collaboration across the ecosystem to foster innovation and raise awareness of the region as a life sciences hub. | Direttore/Membro del Consiglio | - |
Juvenescence Ltd.
 Juvenescence Ltd. Financial ConglomeratesFinance Functions as an investment holding company | Direttore operativo | 20/05/2020 |
The Francis Crick Institute Ltd.
 The Francis Crick Institute Ltd. Investment Trusts/Mutual FundsMiscellaneous Operates as an independent charity that engages in biomedicine research | Corporate Officer/Principal | 01/02/2017 |
Centauri Therapeutics Ltd.
 Centauri Therapeutics Ltd. BiotechnologyHealth Technology Operates as an immunotherapy biotechnology company that engages in discovery and development of novel molecules targeting life threatening diseases | Presidente | 12/07/2022 |
Relation Therapeutics Ltd.
 Relation Therapeutics Ltd. BiotechnologyHealth Technology Operates as an end-to-end biotech developing transformational medicines | Amministratore Delegato | 01/04/2022 |
Precedenti posizioni note di David Roblin
| Società | Posizione | Fine |
|---|---|---|
Summit Therapeutics Ltd.
 Summit Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Engages in the discovery, development and commercialization of novel medicines | Direttore operativo | 31/01/2020 |
The Francis Crick Institute Ltd.
The Francis Crick Institute Ltd. Investment Trusts/Mutual FundsMiscellaneous Operates as an independent charity that engages in biomedicine research | Direttore operativo | 01/01/2017 |
Creabilis SA | Direttore Tecnico/Scientifico/R&S | 01/01/2014 |
| ░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Formazione di David Roblin
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
70
Relazioni di 1° grado
15
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 15 |
|---|---|
Pfizer Inc.
 Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Bayer AG
 Bayer AG Pharmaceuticals: MajorHealth Technology Provides health care, nutrition and high-tech material services | Health Technology |
Summit Therapeutics Ltd.
Summit Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Engages in the discovery, development and commercialization of novel medicines | Health Technology |
University College London
 University College London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nxera Pharma Co., Ltd.
 Nxera Pharma Co., Ltd. Pharmaceuticals: MajorHealth Technology Develops bio pharmaceutical products | Health Technology |
European Federation of Pharmaceutical Industries & Assns
 European Federation of Pharmaceutical Industries & Assns Miscellaneous Commercial ServicesCommercial Services Operates as a trade association which promotes pharmaceutical discovery and development | Commercial Services |
Creabilis Therapeutics Srl
 Creabilis Therapeutics Srl Pharmaceuticals: MajorHealth Technology Manufactures and sells pharmaceutical products | Health Technology |
Destiny Pharma Plc
 Destiny Pharma Plc Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company which develops novel antimicrobial products | Health Technology |
Creabilis Holdings Ltd.
 Creabilis Holdings Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company | Health Technology |
The Francis Crick Institute Ltd.
The Francis Crick Institute Ltd. Investment Trusts/Mutual FundsMiscellaneous Operates as an independent charity that engages in biomedicine research | Miscellaneous |
MedCity Ltd.
MedCity Ltd. MedCity Ltd. is a central organization dedicated to accelerating innovation, investment, and growth within the life sciences sector. The private company is based in Canterbury, UK. It supports a broad range of life sciences companies—including biotech, medtech, diagnostics, digital health, and advanced therapies—by providing expert guidance, tailored business growth services, and access to a network of investors, academia, industry, and the NHS. MedCity runs programs such as Grow, Health Accelerator for Social Enterprise, TechBio Boost, Collaborate to Innovate, and the Investment Hub, which offer accelerators, seed funding, pitch events, mentorship, and strategic partnerships to help SMEs scale, secure investment, and expand internationally. The organization facilitates connections between SMEs and a network of over 400 angel and venture capital investors, and offers a free brokerage service to help companies find R&D and manufacturing lab space across key life science clusters. MedCity provides resources including setup guides for companies relocating or investing, market intelligence reports, sector analyses, and updates on funding and regulatory developments. Through events and newsletters, MedCity keeps stakeholders informed and engaged, emphasizing collaboration across the ecosystem to foster innovation and raise awareness of the region as a life sciences hub. | |
Centauri Therapeutics Ltd.
Centauri Therapeutics Ltd. BiotechnologyHealth Technology Operates as an immunotherapy biotechnology company that engages in discovery and development of novel molecules targeting life threatening diseases | Health Technology |
Creabilis SA | |
Juvenescence Ltd.
Juvenescence Ltd. Financial ConglomeratesFinance Functions as an investment holding company | Finance |
Relation Therapeutics Ltd.
Relation Therapeutics Ltd. BiotechnologyHealth Technology Operates as an end-to-end biotech developing transformational medicines | Health Technology |
